Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2015 April;81(4) > Minerva Anestesiologica 2015 April;81(4):405-18

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036


eTOC

 

ORIGINAL ARTICLES  


Minerva Anestesiologica 2015 April;81(4):405-18

language: English

Bloodstream infections in ICU with increased resistance: epidemiology and outcomes

Dimopoulos G. 1, Koulenti D. 1, 2, Tabah A. 2-4, Poulakou G. 5, Vesin A. 6, 7, Arvaniti K. 8, Lathyris D. 9, Matthaiou D. K. 1, Armaganidis A. 1, Timsit J. F. 4, 6, 7

1 Critical Care Department, Attikon University Hospital, Medical School, University of Athens, Athens, Greece;
2 Burns, Trauma, and Critical Care Research Centre, University of Queensland, Brisbane, Australia;
3 Department of Intensive Care Medicine, Royal Brisbane and Women’s Hospital, Brisbane, Australia;
4 Medical ICU, Albert Michallon University Hospital, Grenoble, France;
5 Fourth Department of Internal Medicine, Attikon University Hospital, Medical School, University of Athens, Athens, Greece;
6 Université Grenoble 1, U 823, Albert Bonniot Institute; Team 11: Outcome of mechanically ventilated patients and respiratory cancers, Grenoble, France;
7 Outcomerea Organization, Paris, France;
8 Critical Care Department, General Hospital “Papageorghiou”, Thessaloniki, Greece;
9 Critical Care Department, General Hospital “G. Gennimatas”, Thessaloniki, Greece


FULL TEXT  


BACKGROUND: Aim of this study was to evaluate the epidemiology and outcomes of hospital-acquired bloodstream infections (HA-BSI) in Greek intensive care units (ICU).
METHODS: Secondary analysis of data from 29 ICU collected during the EUROBACT study, a large prospective, observational, multination survey of HA-BSI. First episodes of HA-BSI acquired in the ICU or within 48 hours prior to admission were recorded.
RESULTS: Gram-negative bacteria predominated namely Acinetobacter sp, Klebsiella sp, Pseudomonas sp (73.3% of monomicrobial infections) followed by Gram-positive cocci (18.3%); fungi (7.6%) and anaerobes (0.8%). Overall 73.3% of isolates were multidrug resistant (MDR), 47.1% extensively resistant (XDR) and 1.2% pan-drug resistant (PDR). Carbapenems were the most frequent empirically prescribed antibiotics, while colistin was the most frequently adequate; for both, calculated mean total daily doses were suboptimal. Overall 28-day all-cause mortality was 33.3%. In the multivariate analysis, factors adversely affecting outcome were higher SOFA score at HA-BSI onset (OR 1.19; 95% CI 1.08-1.31, P=0.0006), need for renal supportive therapy (OR 2.75; 95% CI 1.35-5.59, P=0.0053), and for vasopressors/inotropes (OR 2.68; CI 1.18-6.12, P=0.02); adequate empirical treatment had a protective effect (OR 0.48; CI 0.24-0.95, P=0.03).
CONCLUSION: TIMELY administration of adequately dosed treatment regimens and early ICU admission of critically ill patients could help in improving outcomes.

top of page

Publication History

Cite this article as

Corresponding author e-mail

gdimop@med.uoa.gr